68Ga-PSMA与18F-FDG PET/CT在原发性乳腺印戒细胞腺癌中的应用
本文报告一例40岁女性乳腺印戒细胞腺癌合并氟骨症患者,68Ga-前列腺特异性膜抗原(PSMA)PET/CT在原发灶及转移灶的摄取高于18F-FDG PET/CT,且全身骨骼见弥漫性PSMA摄取增高,可能由氟骨症所致。
要点
- 乳腺印戒细胞腺癌FDG亲和力低,本例68Ga-PSMA在原发灶及转移灶摄取高于18F-FDG。
- 氟骨症可致全身骨骼弥漫性PSMA摄取增高,判读时需注意鉴别。
- 乳腺印戒细胞腺癌预后较传统导管/小叶癌差。
核心结论
- 本例乳腺印戒细胞腺癌的原发灶及转移灶68Ga-PSMA摄取高于18F-FDG摄取。
- 全身骨骼弥漫性PSMA摄取增高可能由氟骨症所致。
研究设计与样本
- 本文为个案报道,对象为1例40岁女性乳腺印戒细胞腺癌合并氟骨症患者。
- 采用68Ga-PSMA PET/CT与18F-FDG PET/CT进行显像。
主要发现
- 68Ga-PSMA在原发灶及转移灶的摄取高于18F-FDG。
- 全身骨骼见弥漫性PSMA摄取增高,可能由氟骨症所致。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Primary signet ring cell adenocarcinoma of the breast is a rare neoplasm. Similar to other mucinous neoplasms, it has low FDG avidity and poor prognosis compared with the traditional ductal/lobular carcinomas. We present a case of a 40-year-old woman with signet ring cell adenocarcinoma and skeletal fluorosis showing higher uptake of Ga-prostate-specific membrane antigen in the primary lesion and the metastatic sites compared with F-FDG on PET/CT imaging. Additionally, diffuse increased prostate-specific membrane antigen uptake was noticed in the entire skeleton, likely due to skeletal fluorosis.
引用
- Parihar AS, Mittal BR, Sood A, et al. 68Ga-Prostate-Specific Membrane Antigen PET/CT and 18F-FDG PET/CT of Primary Signet Ring Cell Breast Adenocarcinoma. Clin Nucl Med. 2018. PMID: 30247208. doi:10.1097/RLU.0000000000002265
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。